A New Era Begins in Contraception: The Vaginal Gel pH Modulator

A New Era Begins in Contraception: The Vaginal Gel pH Modulator

A New Era Begins in Contraception: The Vaginal Gel pH Modulator
RestartResume

Find out how the vaginal pH modulator fits into the spectrum of available contraceptive methods and what non-contraceptive benefits it provides.

Available credits: 0.25

Time to complete: 15 minutes

Released:

Valid until:

Take Post-Test

If you’ve already completed the activity.

  • Overview

    While the use of contraception is a nearly universal experience in the United States, unintended pregnancy rates remain high. With the recent approval of the nonhormonal vaginal pH modulator, there are now more contraceptive options than ever before.

    Join Drs. David Eisenberg and David Portman as they discuss how this new method fits into clinical practice and how it compares to other contraceptive methods.

  • Disclosure of Conflicts of Interest

    In accordance with the ACCME Standards for Commercial Support, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. GLC resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

    Host:
    David L. Eisenberg, MD, MPH, FACOG
    Associate Professor
    Department of Obstetrics & Gynecology
    Washington University in St. Louis School of Medicine
    St. Louis, MO

    Consulting Fees: Medicines360, Sebela Pharmaceuticals Inc.
    Commercial Interest Speaker’s Bureau: Merck
    Ownership Interest: Femasys

    Faculty:
    David J. Portman, MD
    Director Emeritus, Columbus Center for Women’s Health Research
    Adjunct Instructor, Obstetrics and Gynecology
    The Ohio State University College of Medicine
    Columbus, OH

    Advisory Board: Evofem Biosciences
    Consulting Fees: Agile Therapeutics, Sebela Pharmaceuticals
    Research Grants: Agile Therapeutics
    Shareholder: Sermonix Pharmaceuticals 

    Reviewers/Content Planners/Authors:

    • Sean T. Barrett has nothing to disclose.
    • Amanda Hilferty has nothing to disclose.
    • Elizabeth Lurwick has nothing to disclose.
    • Brian P. McDonough, MD, FAAFP, has nothing to disclose.
    • Robert S. Schneider, MSW, has nothing to disclose. 
  • Learning Objectives

    After participating in this educational activity, participants should be better able to:

    • Explain the advantages and drawbacks of vaginal gel pH modulator contraception.
    • Identify the strategies that will overcome the most common misperceptions that clinicians and patients hold regarding gel-based contraceptives that may detract from greater consideration of vaginal pH regulators.
    • Discuss the scientific data underlying the increasing pregnancy rate demonstrated in contemporary clinical trials of contraception.
  • Target Audience

    This activity is designed to meet the educational needs of obstetricians/gynecologists, nurse practitioners, physician assistants, nurses, certified nurse midwives, and primary care physicians with a focus on women’s health.

  • Accreditation and Credit Designation Statements

    Global Learning Collaborative is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    Global Learning Collaborative designates this enduring material for a maximum of .25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Provider

    Omnia Education is the leading provider of education for women’s health professionals. Our activities are recognized nationwide for providing credible, relevant, and practical information on issues impacting the female patient. Additionally, our unique focus has transformed the CME learning environment, and our ability to help learners recognize and overcome barriers to optimal performance and optimal patient outcomes has positioned us as a leader in women’s health education.

  • Commercial Support

    This activity is supported by an independent educational grant from Evofem Biosciences.

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC and Omnia Education. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of Omnia Education you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.

    Reproduction Prohibited

    Reproduction of this material is not permitted without written permission from the copyright owner.

  • System Requirements

    Our site requires a computer, tablet or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/cable). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Internet Explorer, Microsoft Edge, Chrome, Firefox or Safari. Users accustomed to IE8, IE9 IE10 are advised to update their browsers for the best experience.

Facebook Comments

Register

We’re glad to see you’re enjoying Omnia Education…
but how about a more personalized experience?

Register for free